Metabolic Disease Services Platform
Metabolic diseases are considered to arise from multiple factors, including genetics, diet, age, and environmental factors, and often affect various organs throughout the body. No single cause is solely responsible for these disorders.
To support research in this area, WuXi AppTec offers a comprehensive platform of in vitro and in vivo services. Our capabilities include a well-established panel of validated and clinically relevant animal models, as well as advanced technologies for studying obesity, diabetes, hyperlipidemia, and rare metabolic diseases.
• Clinically relevant models that mirror clinical profiles for effective drug screening and assessment.
• Comprehensive system for metabolic disease treatment evaluation.
• Extensive metabolic research experience and robust drug evaluation system.
Learn more about our metabolic disease service platform by clicking HERE
Metabolic Disease Platform
Related Content
Studies have demonstrated that obesity can promote cancer progression through mechanisms that include chronic low-grade inflammation. Previous research with diet-induced...
VIEW RESOURCEMetabolic Dysfunction-Associated Steatohepatitis (MASH) is a severe form of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). MASH is a growing public...
VIEW RESOURCE